Myopia Is Now a Major Health Crisis—But New Treatments Are Changing the Game

Myopia, or nearsightedness, has transformed from a simple vision problem into a global health emergency, with projections showing nearly 50% of the world's population will be affected by 2050. What's particularly alarming is that up to 90% of high school graduates in parts of Asia are already myopic, and this isn't just about needing glasses—severe myopia dramatically increases the risk of blindness from retinal detachment, glaucoma, and other serious eye diseases.

What's Driving This Myopia Epidemic?

The surge in nearsightedness isn't happening by accident. Environmental factors are the primary culprits, particularly increased screen time, excessive close-up work, and dramatically reduced outdoor activity among children and teens. In China, myopia affected 52.7% of children in 2020, with 17.6% of high school students experiencing high myopia—a condition that significantly raises the risk of vision-threatening complications later in life.

The COVID-19 lockdowns provided stark evidence of environmental impact, with sharp increases in myopia among younger children when outdoor activity was curtailed, except in areas where structured outdoor exposure was preserved.

How Are New Treatments Changing Outcomes?

The good news is that revolutionary treatments are showing unprecedented success rates. At the recent International Myopia Conference, researchers presented breakthrough findings that are reshaping how we approach this crisis:

• Specialized Contact Lenses: MiSight 1 day contact lenses reduced eye elongation by 52% at six months and 51% at 12 months in Chinese children, with myopia progression slowed by 57% at the 12-month mark
• Red-Light Therapy: Repeated low-level red-light therapy has emerged as a promising non-invasive intervention, though safety assessments remain crucial as some devices may exceed safe exposure limits
• Low-Dose Atropine: This eye drop treatment remains a cornerstone therapy with consistent efficacy and minimal side effects when used at appropriate concentrations
• Outdoor Time: Simply increasing time spent outdoors remains one of the most reliable protective factors, with Taiwan's school policies promoting outdoor activity showing measurable success in stabilizing myopia trends

"Given the point-source laser on the retina, traditional measures like visual acuity may not effectively detect focal damage," explained Lisa Ostrin, Associate Professor at the University of Houston College of Optometry, highlighting the importance of safety in new red-light treatments.

What Does This Mean for Prevention?

Perhaps most importantly, researchers are now focusing heavily on prevention rather than just treatment. The concept of "hyperopic reserve"—the age-appropriate level of farsightedness that protects against developing myopia—has become central to early intervention strategies. Evidence shows that delaying myopia onset by just one year is comparable to 2-3 years of treatment with current methods.

For parents and children, this means proactive monitoring is crucial. Cycloplegic spherical equivalent error has been established as the single best predictor of myopia onset, allowing eye care professionals to identify at-risk children before they become nearsighted.

The shift from passive correction to active prevention represents a fundamental change in eye care. Long-term studies confirm the safety and sustained efficacy of optical interventions like dual-focus contact lenses and specialized spectacle lenses, with no rebound effects when treatment is discontinued. Success is now defined not just by slowed progression, but by sustained safety, good vision quality, and treatment acceptance over time.